AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2014
May 13, 2014
284_dirs_2014-05-13_e5b93dd5-8686-4bd7-a227-a1bff7a3203e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-09
Reporting Person: Davis Robert M (Exec V-P & Chief Fince Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-09 | Restricted Stock Unit | $ | A | 85881.0000 | Acquired | 2017-05-09 | Common Stock (85881.0000) | Direct |
| 2014-05-09 | Stock Option (right to buy) | $58.2200 | A | 192572.0000 | Acquired | 2024-05-08 | Common Stock (192572.0000) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: The option vests in three equal annual installments beginning May 9, 2015.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30